Nuwellis (NUWE) Gains from Investment Securities (2016 - 2026)
Nuwellis' (NUWE) quarterly Gains from Investment Securities came in at -$26000.0 in Q1 2026, up 35.0% YoY from -$19259.3 in Q1 2025, and up 18.75% on a QoQ basis from -$32000.0 in Q4 2025.
Nuwellis (NUWE) Gains from Investment Securities (2016 - 2026) Analysis & Trends
Nuwellis (NUWE) has 7 years of Gains from Investment Securities data on file, last reported at -$26000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 35.0% year-over-year to -$26000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (up 21.15% YoY) and the FY2025 annual result came in at -$4.1 million, up 10.44% from the prior year.
- Gains from Investment Securities improved to -$26000.0 in Q1 2026, from -$32000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $755000.0 in Q1 2023 to a low of -$11.8 million in Q4 2022.
- A 5-year average of -$1.8 million and a median of -$360000.0 in 2024 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2024 — Gains from Investment Securities surged 99.14% — and 2025, when it slumped 304.04%.
- Tracing NUWE's Gains from Investment Securities over 5 years: stood at -$11.8 million in 2022, then surged by 87.21% to -$1.5 million in 2023, then surged by 99.14% to -$13000.0 in 2024, then plunged by 146.15% to -$32000.0 in 2025, then climbed by 18.75% to -$26000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$26000.0 (Q1 2026), -$32000.0 (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Nuwellis | 212,054.30 | -3.71 Mn | 1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.41 Mn |
| Jun 30, 2026 | -4.41 Mn |
| Mar 31, 2026 | -26,000.00 |
| Mar 31, 2026 | -26,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Dec 31, 2025 | -32,000.00 |
| Sep 30, 2025 | -3.16 Mn |
| Sep 30, 2025 | -3.16 Mn |
| Jun 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Mar 31, 2025 | -40,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Dec 31, 2024 | -13,000.00 |
| Sep 30, 2024 | -3.88 Mn |
| Sep 30, 2024 | -3.88 Mn |
| Jun 30, 2024 | -198,000.00 |
| Jun 30, 2024 | -198,000.00 |
| Mar 31, 2024 | -522,000.00 |
| Mar 31, 2024 | -522,000.00 |